The impact of COVID-19 has been profound, and its presence poses a particular risk for people with intellectual disability – especially for those diagnosed with Alzheimer’s disease or with other causes of dementia.  The NTG is invested to provide information on how the COVID-19 pandemic is affecting adults with intellectual disability and dementia and their families and caregivers. 

On these pages we provide access to the latest version of the Q and A on Down syndrome and COVID-19 and access to a range of COVID-19 related publications and resources.

NTG Statement on COVID-19, Intellectual Disability, and Dementia

This NTG statement, issued December 11, 2020, provides the rationale for placing adults with intellectual disability affected by Alzheimer’s disease and other causes for dementia on priority lists for receiving special consideration in mitigation strategies for managing the spread of COVID-19 and for receiving inoculation by vaccines designed to inhibit infections by the COVID-19 virus.

News stories about impact of COVID-19 and intellectual disability

Journalistic review article from the Associated Press on conditions within group homes for people with intellectual disability.  Contains focus on the greater Chicago area where conditions were examined at homes run by a large residential care agency as well as extensive national information, mostly drawn from data on CMS funded homes.

Authors: Holbrook Mohr, Mitch Weiss, & Reese Dunklin, Associated Press (dateline June 11, 2020)